Skip to main content
. 2017 Oct 6;8(60):101500–101508. doi: 10.18632/oncotarget.21551

Figure 1. Patient selection and classification.

Figure 1

Of the 426 patients who underwent radical nephroureterectomy for UTUC, 234 were identified as having high-risk disease (stages cT3-4 or cN+ disease). Of those patients, 101 received 2 to 4 courses of NAC (NAC group) and 133 did not (Ctrl group) (A). The regimens in the NAC group were GCarbo in 76 patients (75%) and GCis in 21 (21%) (B).